Most Active Stocks

OLAELEC
JPPOWER
BSE
NEULANDLAB
RELIANCE
INFY
ETERNAL
HDFCBANK
TCS
BHARTIARTL
ANANDRATHI
M&M
ICICIBANK
DMART
GRASIM
VMM
GLENMARK
WAAREEENER
BEL
IDEA

Ortin Global Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. It operates through Manufacture and Trading segments. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulcerants, anti-spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti-retroviral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti-ulcerants, and anti-malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; research and development services for new formulation brands; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; operates as a merchant exporter of pharmaceutical finished formulations; and engages in real estate. The company was formerly known as Ortin Laboratories Limited and changed its name to Ortin Global Limited in June 2024. Ortin Global Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

Key Information

Market Cap

93510984

Current Price

11.5

52 Week Range

9.64 - 24.82

Previous Close

11.5

Open

11.93

Contact Details

Address

D. No. 1-8-B4, F3 HIG, Ground Floor Block-4, Street no. 3 Baghlingampally, Telangana, Hyderabad, 500044, India

Phone

+91-40275-62055

Financials

Day Low

11.5

Day High

11.93

Dividend Yield

PE Ratio

Earnings Per Share

-1.04

Beta

0.521

EBITDA

-8423000

Book Value

2.41

EPS

Company Officers

Name Title Age Year Born
Mr. Sanka Murali Krishna Murthy MD & Director 65 1959
Ms. Madhu Mala Solanki Company Secretary & Compliance Officer 33 1991
Mr. Ramesh Joshi Whole-Time Director 38 1986

Company Details

Stock History